Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer.

Guerin M, Gonçalves A, Toiron Y, Baudelet E, Pophillat M, Granjeaud S, Fourquet P, Jacot W, Tarpin C, Sabatier R, Agavnian E, Finetti P, Adelaide J, Birnbaum D, Ginestier C, Charafe-Jauffret E, Viens P, Bertucci F, Borg JP, Camoin L.

Oncotarget. 2018 Sep 18;9(73):33762-33777. doi: 10.18632/oncotarget.26031. eCollection 2018 Sep 18.

2.

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial.

Lebellec L, Bertucci F, Tresch-Bruneel E, Ray-Coquard I, Le Cesne A, Bompas E, Blay JY, Italiano A, Mir O, Ryckewaert T, Toiron Y, Camoin L, Goncalves A, Penel N, Le Deley MC.

BMC Cancer. 2018 Oct 11;18(1):963. doi: 10.1186/s12885-018-4828-1.

3.

Early prognostic factors in septic shock cancer patients: a prospective study with a proteomic approach.

Mokart D, Saillard C, Zemmour C, Bisbal M, Sannini A, Chow-Chine L, Brun JP, Faucher M, Boher JM, Toiron Y, Chabannon C, Borg JP, Gonçalves A, Camoin L.

Acta Anaesthesiol Scand. 2018 Apr;62(4):493-503. doi: 10.1111/aas.13060. Epub 2018 Jan 7.

PMID:
29315472
4.

How may targeted proteomics complement genomic data in breast cancer?

Guerin M, Gonçalves A, Toiron Y, Baudelet E, Audebert S, Boyer JB, Borg JP, Camoin L.

Expert Rev Proteomics. 2017 Jan;14(1):43-54. doi: 10.1080/14789450.2017.1256776. Epub 2016 Nov 15. Review.

PMID:
27813428
5.

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO).

Lebellec L, Bertucci F, Tresch-Bruneel E, Bompas E, Toiron Y, Camoin L, Mir O, Laurence V, Clisant S, Decoupigny E, Blay JY, Goncalves A, Penel N.

Oncotarget. 2016 Nov 8;7(45):73984-73994. doi: 10.18632/oncotarget.12172.

6.

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.

Tabouret E, Bertucci F, Pierga JY, Petit T, Levy C, Ferrero JM, Campone M, Gligorov J, Lerebours F, Roché H, Bachelot T, van Laere S, Ueno NT, Toiron Y, Finetti P, Birnbaum D, Borg JP, Viens P, Chinot O, Gonçalves A.

Oncotarget. 2016 Apr 5;7(14):18531-40. doi: 10.18632/oncotarget.7612.

7.

Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib.

Gilabert M, Launay S, Ginestier C, Bertucci F, Audebert S, Pophillat M, Toiron Y, Baudelet E, Finetti P, Noguchi T, Sobol H, Birnbaum D, Borg JP, Charafe-Jauffret E, Gonçalves A.

PLoS One. 2014 Aug 21;9(8):e104302. doi: 10.1371/journal.pone.0104302. eCollection 2014.

8.

The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression.

Salvador MA, Wicinski J, Cabaud O, Toiron Y, Finetti P, Josselin E, Lelièvre H, Kraus-Berthier L, Depil S, Bertucci F, Collette Y, Birnbaum D, Charafe-Jauffret E, Ginestier C.

Clin Cancer Res. 2013 Dec 1;19(23):6520-31. doi: 10.1158/1078-0432.CCR-13-0877. Epub 2013 Oct 18.

9.

Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents.

Kadra G, Finetti P, Toiron Y, Viens P, Birnbaum D, Borg JP, Bertucci F, Gonçalves A.

Breast Cancer Res Treat. 2012 Apr;132(3):1035-47. doi: 10.1007/s10549-011-1687-8. Epub 2011 Jul 27. Erratum in: Breast Cancer Res Treat. 2012 Jul;134(1):449-51.

PMID:
21792624
10.

Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.

Gonçalves A, Charafe-Jauffret E, Bertucci F, Audebert S, Toiron Y, Esterni B, Monville F, Tarpin C, Jacquemier J, Houvenaeghel G, Chabannon C, Extra JM, Viens P, Borg JP, Birnbaum D.

Mol Cell Proteomics. 2008 Aug;7(8):1420-33. doi: 10.1074/mcp.M700487-MCP200. Epub 2008 Apr 20.

11.

Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers.

Ginestier C, Charafe-Jauffret E, Bertucci F, Eisinger F, Geneix J, Bechlian D, Conte N, Adélaïde J, Toiron Y, Nguyen C, Viens P, Mozziconacci MJ, Houlgatte R, Birnbaum D, Jacquemier J.

Am J Pathol. 2002 Oct;161(4):1223-33.

12.

Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones.

Mozziconacci MJ, Rosenauer A, Restouin A, Fanelli M, Shao W, Fernandez F, Toiron Y, Viscardi J, Gambacorti-Passerini C, Miller WH Jr, Lafage-Pochitaloff M.

Genes Chromosomes Cancer. 2002 Nov;35(3):261-70.

PMID:
12353268
13.

The Philadelphia chromosome as a secondary abnormality in two cases of acute myeloid leukemia.

Mozziconacci MJ, Sainty D, Gabert J, Arnoulet C, Simonetti J, Toiron Y, Costello R, Hagemeijer A, Lafage-Pochitaloff M.

Br J Haematol. 1998 Aug;102(3):873-5. No abstract available.

PMID:
9722319
14.

Cytogenetic and molecular biology for acute leukemias at diagnosis: a cost/effectiveness comparison.

Tonnaire G, Gabert J, Lafage-Pochitaloff M, Mozziconacci MJ, Toiron Y, Sainty D, Maraninchi D, Moatti JP.

Leuk Lymphoma. 1998 Jan;28(3-4):363-70.

PMID:
9517507
15.

Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy.

Eberlé F, Toiron Y, Camerlo J, Lafage M, Sainty D, Arnoulet C, Raineri V, Gabert J, Maraninchi D, Mannoni P.

Leuk Lymphoma. 1995 Jun;18(1-2):153-7.

PMID:
8580818
16.

Philadelphia chromosome-negative chronic myeloid leukaemia: a report of 14 new cases.

Costello R, Lafage M, Toiron Y, Brunel V, Sainty D, Arnoulet C, Mozziconacci MJ, Bouabdallah R, Gastaut JA, Maraninchi D, et al.

Br J Haematol. 1995 Jun;90(2):346-52.

PMID:
7794755
17.

Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells.

Rosnet O, Schiff C, Pébusque MJ, Marchetto S, Tonnelle C, Toiron Y, Birg F, Birnbaum D.

Blood. 1993 Aug 15;82(4):1110-9.

PMID:
8394751

Supplemental Content

Loading ...
Support Center